SOD1 and amyotrophic lateral sclerosis: Indeed, metabolomic analyses suggest that ALS patients show elevated serum levels of glutamate [32], and there is evidence that sporadic and familial ALS cases show heightened levels of cortical excitablity, which can be detected even in the presymptomatic stages in familial SOD1 mutation carriers [162].